|
![]() |
|||
|
||||
OverviewOur remedies are only as good as the way in which we dispense them That's the central premise of Thinking About Prescribing, a new volume that encourages pharmacotherapists to view the prescribing of a psychiatric medication to young patients not simply as part of a clinical visit, but rather as the beginning of an ongoing alliance with youth and their parents or legal guardians. The book makes the case for a partnership that doesn't lean on psychiatric jargon or an encyclopedic list of side effects, but instead on measured candor, vulnerability, and—most importantly—time. Thinking About Prescribing leverages the knowledge of more than two dozen experts as it tackles topics that include: • The essential features of the Common Factors approach and the Y-model of psychotherapy, which highlights how relational aspects of pharmacotherapy are key to child & adolescent psychiatric practice, even for brief visits • How best to utilize the 30-minute Brief Pharmacotherapy Visit (BPV), so that the alliance is nurtured and time is most efficiently utilized • Techniques, adapted from evidence-based psychotherapies, to enhance medication adherence in diverse youth populations • Approaches to adapt psychoeducation for culturally diverse populations, and consider why many youth & families may be skeptical of pharmacotherapeutic interventions • Strategies to cultivate a pharmacotherapeutic alliance when engaging with patients and families via telehealth, including in the school setting • Tips for pediatricians, advanced-practice clinicians, and other primary care providers who conduct pharmacotherapy The chapters feature key takeaways that distill the most salient points and that aid in knowledge retention. Rather than raise unrealistic expectations (two chapters acknowledge the reality of practicing when time and resources are scarce), the goal of this book is to help pharmacotherapists mitigate the stigma, apprehension, or resignation their patients may have and instead build and maintain a trusting relationship that will be key to successful therapeutic outcomes. Full Product DetailsAuthor: Shashank V. Joshi (Associate Professor of Psychiatry, Stanford University) , Andrés Martin, MD MPH (Associate Professor of Psychiatry, Yale University)Publisher: American Psychiatric Association Publishing Imprint: American Psychiatric Association Publishing Dimensions: Width: 15.20cm , Height: 1.70cm , Length: 22.90cm Weight: 0.630kg ISBN: 9781615373888ISBN 10: 1615373888 Pages: 395 Publication Date: 19 March 2022 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsUncoveredPrescriber, Prescribe Thyself (By Way of Introduction)Chapter 1: Think Again About Prescribing: The Psychology of PsychopharmacologyChapter 2: The Many Facets of Alliance: The Y-Model, Applied to Child, Adolescent, and Young Adult PsychopharmacotherapyChapter 3: Psychodynamics of Medication Use in Youth with Serious Mental IllnessChapter 4: What's in It for Me? : Adapting Evidence-Based Motivational Interviewing and Therapy Techniques to Adolescent PsychiatryChapter 5: Providing Psychoeducation in PharmacotherapyChapter 6: #KeepItReal: The Myth of the Med Check and the Realities of the Time-Limited Pharmacotherapy VisitChapter 7: Pharmacotherapy or Psychopharmacotherapy: When Therapist and Pharmacologist Are Different People, or the Same PersonChapter 8: The Pharmacotherapeutic Role of the Pediatrician, Advanced Practice Clinician, and Other Primary Care ProvidersChapter 9: The Pharmacotherapeutic Alliance in School Mental HealthChapter 10: When Time Is Tight and Stakes Are High: Pharmacotherapy, Alliances, and the Inpatient UnitChapter 11: Telepsychiatry Goes Viral: Psychotherapeutic Aspects of Prescribing Via Telemedicine Amid COVID-19Chapter 12: Alliance Issues to Consider in Pharmacotherapy with Transition-Age YouthChapter 13: The Pharmacotherapeutic Alliance When Working with Diverse Youth and FamiliesChapter 14: The Psychopharmacotherapeutic Alliance When Resources Are LimitedChapter 15: Building a Therapeutic Alliance in Psychopharmacology During Clinical Trials: Ethical and Practical ConsiderationsChapter 16: The Power of PlaceboChapter 17: The Good Enough Pediatric Psychopharmacotherapist: Practical Pointers in Six ParablesChapter 18: Teaching and Mentoring the Next Generation of Pediatric PsychopharmacotherapistsGratitudeReviewsAuthor InformationShashank V. Joshi, M.D., is Professor of Psychiatry, Pediatrics, and Education at the Stanford University School of Medicine and Graduate School of Education, Director of School Mental Health at Lucile Packard Children's Hospital, and a Faculty Advisor at the Center for Comparative Studies in Race and Ethnicity (CCSRE), in Stanford, California. Andrés Martin, M.D., M.P.H., is the Riva Ariella Ritvo Professor, Child Study Center, Yale School of Medicine, in New Haven, Connecticut. He is Medical Director of the Children's Psychiatric Inpatient Service at Yale New Haven Health, in New Haven, Connecticut. Tab Content 6Author Website:Countries AvailableAll regions |